CLDN18 is a marker for the early carcinogenetic process in PDAC because all three types of precursor lesions (PanIN, IPMN, and MCN) exhibit frequent immunoreactivity for CLDN18. The gene discussed is CLDN18; the disease is pancreatic intraductal papillary-mucinous neoplasm.